These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28152251)

  • 1. Diffusion-weighted MRI treatment monitoring of primary hypofractionated proton and carbon ion prostate cancer irradiation using raster scan technique.
    Wolf MB; Edler C; Tichy D; Röthke MC; Schlemmer HP; Herfarth K; Bonekamp D
    J Magn Reson Imaging; 2017 Sep; 46(3):850-860. PubMed ID: 28152251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic contrast enhanced MRI monitoring of primary proton and carbon ion irradiation of prostate cancer using a novel hypofractionated raster scan technique.
    Bonekamp D; Wolf MB; Edler C; Katayama S; Schlemmer HP; Herfarth K; Röthke M
    Radiother Oncol; 2016 Aug; 120(2):313-9. PubMed ID: 27237059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive role of ADC values in prostate cancer patients treated with carbon-ion radiotherapy: initial clinical experience at Shanghai Proton and Heavy Ion Center (SPHIC).
    Qi WX; Zhang Q; Li P; Zhang XM; Zhang GY; Wu B; Lu JJ; Jiang GL; Fu S
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1361-7. PubMed ID: 27008005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DWI of the prostate: Comparison of a faster diagonal acquisition to standard three-scan trace acquisition.
    Corcuera-Solano I; Wagner M; Hectors S; Lewis S; Titelbaum N; Stemmer A; Rastinehad A; Tewari A; Taouli B
    J Magn Reson Imaging; 2017 Dec; 46(6):1767-1775. PubMed ID: 28301097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T.
    Song I; Kim CK; Park BK; Park W
    AJR Am J Roentgenol; 2010 Jun; 194(6):W477-82. PubMed ID: 20489065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Stratification of Prostate Cancer Using the Combination of Histogram Analysis of Apparent Diffusion Coefficient Across Tumor Diffusion Volume and Clinical Information: A Pilot Study.
    Zhang Z; Xu H; Xue Y; Li J; Ye Q
    J Magn Reson Imaging; 2019 Feb; 49(2):556-564. PubMed ID: 30173421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-weighted imaging to evaluate for changes from androgen deprivation therapy in prostate cancer.
    Kim AY; Kim CK; Park SY; Park BK
    AJR Am J Roentgenol; 2014 Dec; 203(6):W645-50. PubMed ID: 25415730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early changes in apparent diffusion coefficient from diffusion-weighted MR imaging during radiotherapy for prostate cancer.
    Park SY; Kim CK; Park BK; Park W; Park HC; Han DH; Kim B
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):749-55. PubMed ID: 22154286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion weighted MRI as an early predictor of tumor response to hypofractionated stereotactic boost for prostate cancer.
    Pasquier D; Hadj Henni A; Escande A; Tresch E; Reynaert N; Colot O; Lartigau E; Betrouni N
    Sci Rep; 2018 Jul; 8(1):10407. PubMed ID: 29991748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of computed diffusion-weighted MRI for predicting aggressiveness of prostate cancer.
    Waseda Y; Yoshida S; Takahara T; Kwee TC; Matsuoka Y; Saito K; Kihara K; Fujii Y
    J Magn Reson Imaging; 2017 Aug; 46(2):490-496. PubMed ID: 28152258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing structure of normal and malignant prostate tissue before and after radiation therapy with luminal water fraction and diffusion-weighted MRI.
    Carlin D; Orton MR; Collins D; deSouza NM
    J Magn Reson Imaging; 2019 Aug; 50(2):619-627. PubMed ID: 30589150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histogram analysis of stretched-exponential and monoexponential diffusion-weighted imaging models for distinguishing low and intermediate/high gleason scores in prostate carcinoma.
    Liu W; Liu XH; Tang W; Gao HB; Zhou BN; Zhou LP
    J Magn Reson Imaging; 2018 Aug; 48(2):491-498. PubMed ID: 29412492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incremental value of high b value diffusion-weighted magnetic resonance imaging at 3-T for prediction of extracapsular extension in patients with prostate cancer: preliminary experience.
    Kido A; Tamada T; Sone T; Kanomata N; Miyaji Y; Yamamoto A; Ito K
    Radiol Med; 2017 Mar; 122(3):228-238. PubMed ID: 27943099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring radiotherapy induced tissue changes in localized prostate cancer by multi-parametric magnetic resonance imaging (MP-MRI).
    Wu X; Reinikainen P; Kapanen M; Vierikko T; Ryymin P; Kellokumpu-Lehtinen PL
    Diagn Interv Imaging; 2019 Nov; 100(11):699-708. PubMed ID: 31257114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion radiomics analysis of intratumoral heterogeneity in a murine prostate cancer model following radiotherapy: Pixelwise correlation with histology.
    Lin YC; Lin G; Hong JH; Lin YP; Chen FH; Ng SH; Wang CC
    J Magn Reson Imaging; 2017 Aug; 46(2):483-489. PubMed ID: 28176411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploratory study of geometric distortion correction of prostate diffusion-weighted imaging using B
    Tong A; Lemberskiy G; Huang C; Shanbhogue K; Feiweier T; Rosenkrantz AB
    J Magn Reson Imaging; 2019 Nov; 50(5):1614-1619. PubMed ID: 30990941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate Cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRI.
    Hötker AM; Mazaheri Y; Zheng J; Moskowitz CS; Berkowitz J; Lantos JE; Pei X; Zelefsky MJ; Hricak H; Akin O
    Eur Radiol; 2015 Sep; 25(9):2665-72. PubMed ID: 25820537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted MRI Provides a Useful Biomarker for Evaluation of Radiotherapy Efficacy in Patients with Prostate Cancer.
    Wu X; Reinikainen P; Kapanen M; Vierikko T; Ryymin P; Kellokumpu-Lehtinen PL
    Anticancer Res; 2017 Sep; 37(9):5027-5032. PubMed ID: 28870929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted MRI of urinary bladder and prostate cancers.
    Kiliçkesmez O; Cimilli T; Inci E; Kayhan A; Bayramoğlu S; Taşdelen N; Gürmen N
    Diagn Interv Radiol; 2009 Jun; 15(2):104-10. PubMed ID: 19517380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.